-
Published 5/23/2024
Allegretti JR, Bordeianou LG, Damas OM, Eisenstein S, Greywoode R, Minar P, Singh S, Harmon S, Lisansky E, Malone-King M, Litwin NS, Weaver A, Heller CA, Moss AC, Adler J. Challenges in IBD Research 2024: Pragmatic Clinical Research. Inflamm Bowel Dis. 2024 May 23; 30(Supplement_2):S55-S66. PMID: 38778623.
-
Published 5/23/2024
Prasad S, Cross RK, Monroe MB, Dolinger MT, Motte R, Hong S, Stidham RW, Kumar N, Levine D, Larijani A, Simone A, Chachu KA, Wyborski R, Heller CA, Moss AC, Schwerbrock NMJ, Selaru FM. Challenges in IBD Research 2024: Novel Technologies. Inflamm Bowel Dis. 2024 May 23; 30(Supplement_2):S30-S38. PMID: 38778625.
-
Published 5/23/2024
Heller C, Moss AC, Rubin DT. Overview to Challenges in IBD 2024-2029. Inflamm Bowel Dis. 2024 May 23; 30(Supplement_2):S1-S4. PMID: 38778626.
-
Published 5/23/2024
Ciorba MA, Konnikova L, Hirota SA, Lucchetta EM, Turner JR, Slavin A, Johnson K, Condray CD, Hong S, Cressall BK, Pizarro TT, Hurtado-Lorenzo A, Heller CA, Moss AC, Swantek JL, Garrett WS. Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms. Inflamm Bowel Dis. 2024 May 23; 30(Supplement_2):S5-S18. PMID: 38778627.
-
Published 4/12/2023
Kohli A, Moss AC. Personalizing therapy selection in inflammatory bowel disease. Expert Rev Clin Immunol. 2023 Apr; 19(4):431-438. PMID: 37051666.